Arlington Partners LLC Mckesson Corp Transaction History

Arlington Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$437.42 - $470.64 $1,312 - $1,411	-3 Reduced 4.69%	61 $28,000
Q3 2023 Oct 24, 2023	SELL	$402.4 - $446.42 $366,184 - $406,242	-910 Reduced 93.43%	64 $27,000
Q1 2023 Apr 26, 2023	BUY	$335.35 - $386.06 $263,585 - $303,443	786 Added 418.09%	974 $346,000
Q1 2022 Apr 14, 2022	SELL	$244.61 - $310.48 $6,849 - $8,693	-28 Reduced 12.96%	188 $58,000
Q4 2021 Jan 18, 2022	SELL	$198.21 - $248.9 $71,950 - $90,350	-363 Reduced 62.69%	216 $54,000
Q3 2021 Oct 15, 2021	BUY	$188.42 - $208.66 $109,095 - $120,814	579 New	579 $115,000
Q2 2020 Jul 13, 2020	SELL	$125.49 - $164.68 $2,509 - $3,293	-20 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$115.75 - $170.96 $2,315 - $3,419	20 New	20 $3,000

1,690

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $89.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.